Dr Lal Pathlabs Ltd Share Price (LALPATHLAB)
Check the latest share price of Dr Lal Pathlabs Ltd, along with the price target, peer comparison, quarterly results, recent news, expert analysis, shareholding pattern, and other key fundamentals to make informed investment decisions.
as on 04:01PM, 30 Jun 2025
NSE
Dr Lal Pathlabs Ltd Stock Performance
Get live Dr Lal Pathlabs Ltd share price, day's high and low, historical returns, and market stats.
Day's Low
Day's High
₹2,782.7Day's Price Range₹2,824.252 Week's Low
52 Week's High
₹2,293.5552-Week Price Range₹3,653.95
| Returns % | |
| 1 Month Return | -0.64 % |
| 3 Month Return | + 15.4 % |
| 1 Year Return | -1.93 % |
| 3 Year Return | + 28.17 % |
| 5 Year Return | + 76.98 % |
| Market Stats | |
| Previous Close | ₹2,768.90 |
| Open | ₹2,785.00 |
| Volume | 62.46K |
| Upper Circuit | ₹3,322.60 |
| Lower Circuit | ₹2,215.20 |
Dr Lal Pathlabs Ltd Fundamentals & Key Indicators
Check Dr Lal Pathlabs Ltd market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
₹23,196.60 Cr
Return on Equity (ROE)
25.27
PE Ratio (TTM)
47.35
Return on capital employed (ROCE)
29.72
Industry PE ratio
103.62
Beta (LTM)
0.4
P/B Ratio
9.71
Dividend Yield
0.97
PEG Ratio
3.06
Quarterly Earnings Growth YOY
81.24
EPS (TTM)
58.89
Sector
Healthcare
Book Value
259.92
Technical Analysis
Bearish
View Technical Analysis
How to invest in Dr Lal Pathlabs Ltd?
Investing in Dr Lal Pathlabs Ltd is simple. You can open a free INDstocks investment account on the INDmoney App. Search for Dr Lal Pathlabs Ltd or LALPATHLAB on the app to check live prices of the stock and click on Buy or SIP. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.
For example: You can buy 10 shares of Dr Lal Pathlabs Ltd or start an SIP based on the market price on each investment date.
You can easily transfer money to your stock account via the INDmoney app and start investing in stocks like Dr Lal Pathlabs Ltd with just a few clicks!
Dr Lal Pathlabs Ltd Stock's Interest Amongst Investors
Dr Lal Pathlabs Ltd Valuation
Track how Dr Lal Pathlabs Ltd P/E has moved over time to understand its valuation trends.
Dr Lal Pathlabs Ltd in the last 5 years
Lowest (37.51x)
November 16, 2018
Today (47.35x)
June 27, 2025
Industry (103.62x)
June 27, 2025
Highest (95.62x)
November 5, 2020
Today’s Price to Earnings Ratio: 47.35x
Dr Lal Pathlabs Ltd Stock Recommendation
Get updated buy, sell, and hold recommendations by analysts on Dr Lal Pathlabs Ltd.
based on 25 analysts
60.00%
Buy
12.00%
Hold
28.00%
Sell
60% of analysts recommend a 'HOLD' rating for Dr Lal Pathlabs Ltd. Average target price of ₹3079.4
Source: S&P Global Market Intelligence
Dr Lal Pathlabs Ltd Share Price Target
Get share price movements and forecasts by analysts on Dr Lal Pathlabs Ltd.
Dr Lal Pathlabs Ltd price forecast by 25 analysts
Upside of11.21%
High
₹3700
Target
₹3079.40
Low
₹2110
Dr Lal Pathlabs Ltd target price ₹3079.4, a slight upside of 11.21% compared to current price of ₹2796.3. According to 25 analysts rating.
Excluding Excise Duty and Other Income, represents Net Revenue
Dr Lal Pathlabs Ltd revenue growth forecast
Expected growth rate Q1, FY2027:25.22%
Forecast
Actual
Including amortisation and stock based compensations
Dr Lal Pathlabs Ltd EPS growth forecast
EPS estimate Q1, FY2027:19.80%
Forecast
Actual
Source: S&P Global Market Intelligence
Dr Lal Pathlabs Ltd Financial Results
Get the annual and quarterly financial summary of Dr Lal Pathlabs Ltd, including revenue, profit, loss and more.
Indices Featuring Dr Lal Pathlabs Ltd Stock
Check stock indices that include Dr Lal Pathlabs Ltd.
Dr Lal Pathlabs Ltd Earnings and Dividends
View detailed summary of the earnings and dividend history of Dr Lal Pathlabs Ltd.
Dr Lal Pathlabs Ltd Earnings Results
Dr Lal Pathlabs Ltd’s net profit jumped 83.2% since last year same period to ₹154.80Cr in the Q4 2024-2025. On a quarterly growth basis, Dr Lal Pathlabs Ltd has generated 60.08% jump in its net profits since last 3-months.
Read More about Earnings ResultsDr Lal Pathlabs Ltd Dividends April,2025
In the quarter ending March 2025, Dr Lal Pathlabs Ltd has declared dividend of ₹6 - translating a dividend yield of 1.07%.
Read More about Dividends
Dr Lal Pathlabs Ltd Shareholding Pattern
View the shareholding pattern breakup of promoters, FIIs, DIIs, and retail investors in Dr Lal Pathlabs Ltd.
| Investors | Holdings % | Quarterly Trend | 3M change |
|---|---|---|---|
| Promoter Holdings | 53.91% | 0.00 | |
| Foreign Institutions | 23.91% | 0.00 | |
| Mutual Funds | 12.84% | 0.00 | |
| Retail Investors | 5.84% | 0.00 | |
| Others | 3.51% | 0.00 |
Dr Lal Pathlabs Ltd vs Peers
Compare market cap, revenue, PE, and other key metrics of Dr Lal Pathlabs Ltd with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| HOLD | 23,196.60 | 15.4% | 0.53 | 492 | 2,461 | |
| HOLD | 37,844.74 | 115.1% | 0.69 | 354 | 5,553 | |
| HOLD | 58,664.57 | 21.43% | 0.56 | 1,811 | 12,667 | |
| BUY | 10,161.92 | 11.92% | 0.64 | 119 | 547 | |
| BUY | 5,281.96 | 19.2% | 0.54 | 69 | 571 |
Dr Lal Pathlabs Ltd News & Key Events
Latest news and events in one place to help you make informed investing decisions in Dr Lal Pathlabs Ltd.
Dr. Lal PathLabs Expands Genomics and Growth Outlook - 25 Jun, 2025
Dr. Lal PathLabs is enhancing its genomics capabilities with Illumina's NovaSeq X Series and is confident in achieving double-digit growth, according to Nuvama analysts.Dr Lal PathLabs Shares Decline Amid Amazon Competition - 23 Jun, 2025
Dr Lal PathLabs experienced a decline in shares over 2% following Amazon India's entry into the diagnostics market, despite reporting strong Q4 FY25 earnings with an 81.4% YoY profit surge.Dr. Lal PathLabs Reports Strong FY25 Financials - 03 Jun, 2025
Dr. Lal PathLabs, a leading diagnostic chain, reported FY25 revenue of ₹2,461 crore, up 10.5% YoY. EBITDA rose 14.2% to ₹696 crore, with a 28.3% margin. PAT increased by 35.9% to ₹492 crore, reflecting a 20% net margin.Dr Lal PathLabs Faces Controversy Over Gender Testing - 02 Jun, 2025
Dr Lal PathLabs is in the spotlight following a leaked report indicating Olympic boxer Imane Khelif has male chromosomes, leading to her disqualification from women's boxing events. This controversy raises questions about gender eligibility in sports, especially after Khelif's gold win at the 2024 Paris Olympics.
Insights on Dr Lal Pathlabs Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTProfit Spike
Netprofit is up for the last 2 quarters, 96.7 Cr → 154.8 Cr (in ₹), with an average increase of 37.5% per quarter
- POSITIVE IMPACT
MF Holding Up
Mutual Funds have increased holdings from 10.25% to 12.84% in Mar 2025 quarter
- POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 2 quarters, 621.8 Cr → 628.4 Cr (in ₹), with an average increase of 1.1% per quarter
- POSITIVE IMPACT
Retail Holding Up
Retail Investor have increased holdings from 5.82% to 5.84% in Mar 2025 quarter
NO EFFECTAgainst Peers
In the last 1 year, Narayana Hrudayalaya Ltd has given 86.1% return, outperforming this stock by 88.0%
- NO EFFECT
Against Peers
In the last 3 years, Narayana Hrudayalaya Ltd has given 257.8% return, outperforming this stock by 229.6%
- NO EFFECT
Promoter Holding Unchanged
Promoters holdings remained unchanged at 53.91% of holdings in Mar 2025 quarter
NEGATIVE IMPACTFII Holding Down
Foreign Institutions have decreased holdings from 26.82% to 23.91% in Mar 2025 quarter
- NEGATIVE IMPACT
Price Dip
In the last 7 days, LALPATHLAB stock has moved down by -1.3%
About Dr Lal Pathlabs Ltd
The company's top products include pathology tests, imaging tests, and preventive health check-ups. Its popular brands include Dr Lal PathLabs, Lal PathLabs, and Lal PathLabs Diagnostics. Dr Lal PathLabs Ltd has over 2000 labs across India, with more than 2000 collection centers, and over 20000 trained professionals. The company is also present in Nepal, Sri Lanka, and Bangladesh.
Dr Lal PathLabs Ltd is committed to providing quality healthcare services and products to its customers. It is ISO 9001:2015 certified and has been accredited by the National Accreditation Board for Testing and Calibration Laboratories (NABL).
Revenue: ₹602.60Cr as on March 2025 (Q4 FY25)
Net Profit: ₹155.50Cr as on March 2025 (Q4 FY25)
Listing date: 23 Dec, 2015
Chairperson Name: Arvind Lal
| Organisation | Dr Lal Pathlabs Ltd |
| Headquarters | Gurgaon |
| Industry | Healthcare |
| CEO | Arvind Lal |
| E-voting on shares | Click here to vote |
Mutual Funds that own Dr Lal Pathlabs Ltd
Check out the Mutual Funds with significant holdings in Dr Lal Pathlabs Ltd.
FAQs
What is Dr Lal Pathlabs Ltd share price today?
Dr Lal Pathlabs Ltd share price today stands at ₹2796.3, Open: ₹2785, Previous Close: ₹2768.9, High: ₹2824.2, Low: ₹2782.7, 52 Week High: ₹3653.95, 52 Week Low: ₹2293.55.
What is today's traded volume of Dr Lal Pathlabs Ltd?
Today's traded volume of Dr Lal Pathlabs Ltd is 62.46K. Which means that 62.46K shares of Dr Lal Pathlabs Ltd were bought and sold on the stock market during today's trading session.
What is Dr Lal Pathlabs Ltd's market cap today?
Today's market capitalisation of Dr Lal Pathlabs Ltd is ₹23,196.60 Cr. Market cap or market capitalisation is the total value of a company’s outstanding shares in the stock market, calculated by multiplying the current share price by the total number of shares issued by the company.
What is the 52 week high and 52 week low range of Dr Lal Pathlabs Ltd?
Dr Lal Pathlabs Ltd’s 52 week high is ₹3653.95 and 52 week low is ₹2293.55. The current share price of Dr Lal Pathlabs Ltd is ₹2796.3, which is -23.47% down from its 52 week high and 21.92% up from its 52 week low.